Brooke Harmon

638 total citations
16 papers, 443 citations indexed

About

Brooke Harmon is a scholar working on Infectious Diseases, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Brooke Harmon has authored 16 papers receiving a total of 443 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 6 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Molecular Biology. Recurrent topics in Brooke Harmon's work include Monoclonal and Polyclonal Antibodies Research (6 papers), HIV Research and Treatment (4 papers) and CRISPR and Genetic Engineering (3 papers). Brooke Harmon is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (6 papers), HIV Research and Treatment (4 papers) and CRISPR and Genetic Engineering (3 papers). Brooke Harmon collaborates with scholars based in United States and Russia. Brooke Harmon's co-authors include Lee Ratner, Nancy Campbell, Oscar Negrete, Benjamin Schudel, Tetsuro Ikegami, Chien‐Te K. Tseng, Joseph S. Schoeniger, Benhur Lee, David S.H. Chu and Hector C. Aguilar and has published in prestigious journals such as Journal of Biological Chemistry, Analytical Chemistry and Journal of Virology.

In The Last Decade

Brooke Harmon

16 papers receiving 435 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brooke Harmon United States 11 167 139 124 92 86 16 443
Marcy L. Vana United States 7 86 0.5× 153 1.1× 151 1.2× 76 0.8× 132 1.5× 9 404
Gwen M. Taylor United States 13 185 1.1× 180 1.3× 107 0.9× 162 1.8× 155 1.8× 29 601
Bridget A. Robinson United States 14 193 1.2× 201 1.4× 195 1.6× 179 1.9× 184 2.1× 21 588
Salim Bounou Canada 11 98 0.6× 155 1.1× 259 2.1× 338 3.7× 69 0.8× 18 576
Sukun Luo China 13 99 0.6× 161 1.2× 96 0.8× 165 1.8× 184 2.1× 30 485
Yoshii Nishino Japan 14 103 0.6× 143 1.0× 152 1.2× 119 1.3× 138 1.6× 27 422
L M Carruth United States 8 56 0.3× 147 1.1× 133 1.1× 173 1.9× 100 1.2× 9 409
Christopher Sample United States 10 82 0.5× 148 1.1× 26 0.2× 110 1.2× 90 1.0× 17 369
Emily Burke United States 8 333 2.0× 152 1.1× 34 0.3× 114 1.2× 238 2.8× 17 689
Madoka Kuramitsu Japan 14 61 0.4× 192 1.4× 65 0.5× 237 2.6× 126 1.5× 44 462

Countries citing papers authored by Brooke Harmon

Since Specialization
Citations

This map shows the geographic impact of Brooke Harmon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brooke Harmon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brooke Harmon more than expected).

Fields of papers citing papers by Brooke Harmon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brooke Harmon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brooke Harmon. The network helps show where Brooke Harmon may publish in the future.

Co-authorship network of co-authors of Brooke Harmon

This figure shows the co-authorship network connecting the top 25 collaborators of Brooke Harmon. A scholar is included among the top collaborators of Brooke Harmon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brooke Harmon. Brooke Harmon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Sheffield, Thomas, Anupama Sinha, Zhuoming Liu, et al.. (2025). Nanobody screening and machine learning guided identification of cross-variant anti-SARS-CoV-2 neutralizing heavy-chain only antibodies. PLoS Pathogens. 21(1). e1012903–e1012903. 1 indexed citations
2.
Holland, J. F., Daniel Gelperin, Valeria Busygina, et al.. (2025). Combining computational modeling and experimental library screening to affinity‐mature VEEV ‐neutralizing antibody F5. Protein Science. 34(2). e70043–e70043. 1 indexed citations
3.
Sinha, Anupama, et al.. (2024). Therapeutic efficacy of a potent anti-Venezuelan equine encephalitis virus antibody is contingent on Fc effector function. mAbs. 16(1). 2297451–2297451. 3 indexed citations
4.
Harmon, Brooke, et al.. (2023). The Structure of Scientific Writing: An Empirical Analysis of Recent Research Articles in STEM. Journal of Technical Writing and Communication. 54(3). 265–281. 5 indexed citations
5.
Light, Yooli Kim, Colleen M. Courtney, Edwin A. Saada, et al.. (2021). Development of potent and effective synthetic SARS-CoV-2 neutralizing nanobodies. mAbs. 13(1). 1958663–1958663. 13 indexed citations
6.
Seamon, Kyle J., Joseph S. Schoeniger, Brooke Harmon, et al.. (2019). Ultrasensitive multi-species detection of CRISPR-Cas9 by a portable centrifugal microfluidic platform. Analytical Methods. 11(5). 559–565. 23 indexed citations
7.
Seamon, Kyle J., Yooli Kim Light, Edwin A. Saada, Joseph S. Schoeniger, & Brooke Harmon. (2018). Versatile High-Throughput Fluorescence Assay for Monitoring Cas9 Activity. Analytical Chemistry. 90(11). 6913–6921. 17 indexed citations
8.
Harmon, Brooke, Lily A. Chylek, Yanli Liu, et al.. (2017). Timescale Separation of Positive and Negative Signaling Creates History-Dependent Responses to IgE Receptor Stimulation. Scientific Reports. 7(1). 15586–15586. 10 indexed citations
9.
Harmon, Brooke, Sara W. Bird, Benjamin Schudel, et al.. (2016). A Genome-Wide RNA Interference Screen Identifies a Role for Wnt/β-Catenin Signaling during Rift Valley Fever Virus Infection. Journal of Virology. 90(16). 7084–7097. 34 indexed citations
10.
Schudel, Benjamin, Brooke Harmon, Vinay V. Abhyankar, et al.. (2013). Microfluidic platforms for RNA interference screening of virus–host interactions. Lab on a Chip. 13(5). 811–811. 12 indexed citations
11.
Harmon, Brooke, et al.. (2013). Identification of Critical Amino Acids within the Nucleoprotein of Tacaribe Virus Important for Anti-interferon Activity. Journal of Biological Chemistry. 288(12). 8702–8711. 22 indexed citations
12.
Harmon, Brooke, et al.. (2012). Cysteines in the Stalk of the Nipah Virus G Glycoprotein Are Located in a Distinct Subdomain Critical for Fusion Activation. Journal of Virology. 86(12). 6632–6642. 48 indexed citations
13.
Harmon, Brooke, et al.. (2012). Rift Valley Fever Virus Strain MP-12 Enters Mammalian Host Cells via Caveola-Mediated Endocytosis. Journal of Virology. 86(23). 12954–12970. 76 indexed citations
14.
Harmon, Brooke, Nancy Campbell, & Lee Ratner. (2010). Role of Abl Kinase and the Wave2 Signaling Complex in HIV-1 Entry at a Post-Hemifusion Step. PLoS Pathogens. 6(6). e1000956–e1000956. 95 indexed citations
15.
Harmon, Brooke & Lee Ratner. (2008). Induction of the Gα q Signaling Cascade by the Human Immunodeficiency Virus Envelope Is Required for Virus Entry. Journal of Virology. 82(18). 9191–9205. 70 indexed citations
16.
Pontow, Suzanne, Brooke Harmon, Nancy Campbell, & Lee Ratner. (2007). Antiviral activity of a Rac GEF inhibitor characterized with a sensitive HIV/SIV fusion assay. Virology. 368(1). 1–6. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026